Advertisement

Topics

Dissolution Test Failure Leads to Teva Schizophrenia Product Recall

07:00 EDT 19 Jun 2017 | PharmPro

Teva Pharmaceuticals, USA extends voluntary nationwide recall to consumer/user level for one lot of Paliperidone Extended-Relief Tablets, 3mg, 90 count bottles distributed under the Actavis Pharma Inc. label due to dissolution test failure.
Contributed Author: 
Teva Pharmaceuticals USA, Inc.
Topics: 

Original Article: Dissolution Test Failure Leads to Teva Schizophrenia Product Recall

NEXT ARTICLE

More From BioPortfolio on "Dissolution Test Failure Leads to Teva Schizophrenia Product Recall"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...